Detail information
| ID | ENOM00111 | ||||||||||||||||||||||||||||
| Accession | GSE216965 | ||||||||||||||||||||||||||||
| Status | Public on Oct 17, 2023 | ||||||||||||||||||||||||||||
| Title | Epigenetic regulation of beta-endorphin synthesis in hypothalamic arcuate nucleus neurons modulates neuropathic pain in a rodent pain model | ||||||||||||||||||||||||||||
| Organism | Rattus norvegicus | ||||||||||||||||||||||||||||
| Experiment type | Non-coding RNA profiling by high throughput sequencing | ||||||||||||||||||||||||||||
| Summary |
Beta-endorphinergic neurons in the hypothalamic arcuate nucleus (ARC) synthesize beta-endorphin (β-EP) to alleviate nociceptive behaviors, although the underlying regulatory mechanisms remain unknown. Here, we elucidated a novel epigenetic pathway driven by microRNA regulation of beta-endorphin synthesis in ARC neurons to control neuropathic pain. In pain-injured rats miR-203a-3p was the most highly upregulated miRNA in the ARC. A similar increase was identified in the cerebrospinal fluid of trigeminal neuralgia patients. Mechanistically, histone deacetylase 9 downregulation increased acetylation of histone H3 lysine-18, facilitating the binding of NR4A2 transcription factor to the miR-203a-3p gene promoter increasing miR-203a-3p expression following nerve injury. Further, increased miR-203a-3p was found to maintain neuropathic pain by targeting proprotein convertase 1, an endopeptidase necessary for the cleavage of proopiomelanocortin, the precursor of β-EP. Our findings highlight an epigenetic regulatory pathway for β-EP synthesis that contributes to neuropathic pain development and maintenance mechanisms providing for new therapeutic targets for neuropathic pain treatment.
|
||||||||||||||||||||||||||||
| Samples |
|
||||||||||||||||||||||||||||
| Platform | GPL24688: HiSeq X Ten (Rattus norvegicus) | ||||||||||||||||||||||||||||
| Indicator |
miR-30d-5p,
miR-199a-5p,
miR-203a-3p,
miR-451-5p
|
||||||||||||||||||||||||||||
| Download | Download data in GEO database |
